GemVax&KAEL Co.Ltd (082270) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.14x

GemVax&KAEL Co.Ltd (082270) has a Cash Flow Reinvestment Rate of 0.14x as of December 2025, reinvesting ₩1.48 Billion (capex ₩1.43 Billion plus investments ₩-53.31 Million) from operating cash flow of ₩10.34 Billion. Explore how much does GemVax&KAEL Co.Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.14x
(Capex + Investments) / Operating CF

Total Reinvested

₩1.48 Billion
Capex + Investments

Operating Cash Flow

₩10.34 Billion
KRW

Capital Expenditures

₩1.43 Billion
KRW

GemVax&KAEL Co.Ltd Cash Flow Reinvestment Rate (2011–2025)

Historical reinvestment intensity for GemVax&KAEL Co.Ltd across 5 annual periods. Also explore 082270 current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for GemVax&KAEL Co.Ltd (2011–2025)

Year-by-year capital reinvestment analysis for GemVax&KAEL Co.Ltd. For live market cap and broader valuation context, see market value of GemVax&KAEL Co.Ltd.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2025 3.26x ₩3.61 Billion ₩1.11 Billion ₩2.11 Billion ▼ -38.7%
2023 5.32x ₩18.98 Billion ₩3.57 Billion ₩8.46 Billion ▲ +196.7%
2020 1.79x ₩25.03 Billion ₩13.95 Billion ₩10.37 Billion ▲ +54.1%
2014 1.16x ₩12.38 Billion ₩10.64 Billion ₩1.31 Billion ▲ +174.5%
2011 0.42x ₩3.15 Billion ₩7.42 Billion ₩3.15 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow